MedTech News
.................... by Andrew Celentano
Ultrasound has potential to alter how the brain responds to pain
Using ultrasound to stimulate a specific part of the brain could offer a noninvasive therapy that benefits those experiencing chronic pain, a new study has suggested.
Cepheid Receives CE Marking Under IVDR for Xpert® GI Panel
IVDR-compliant PCR test supports detection of 11 clinically relevant gastrointestinal pathogens from 1 sample
Personalized Brain Cancer Vaccine May Help Against Aggressive Glioblastoma
Glioblastoma is one of the deadliest forms of brain cancer, and despite surgery, radiation, and chemotherapy, the disease almost always returns. Part of the reason is that these tumors are remarkably good at evading the immune system.
Parvovirus Is Spreading Across Northern California — but Many Still Think of Parvo as a Dog Disease
A virus many people associate with sick puppies is once again spreading across parts of the U.S., but this outbreak involves a completely different virus that infects humans.
Wearable polygraph detects hidden stress
The body can notice stress before the conscious brain — and that’s no lie
Roche’s Elecsys pTau217 blood test secures CE mark for Alzheimer’s
The CE mark was granted based on data from retrospective studies in real-world early cognitive decline population.
Epineuron wins FDA clearance for nerve stimulator
Epineuron announced today that it received FDA 510(k) clearance for its Evala nerve stimulator technology.
First-in-human trial demonstrates promise of implantable cytokine factories for ovarian cancer
Researchers at Rice University, in collaboration with The University of Texas MD Anderson Cancer Center and clinical partners, have reported results from a first-in-human trial evaluating a novel cell-based platform for localized delivery of interleukin-2 (IL-2) in patients with advanced ovarian cancer.